This article is part of the supplement: Basic science, rationale, background and future of abatacept
Email this article to a friend
The evolving clinical profile of abatacept (CTLA4–Ig): a novel co-stimulatory modulator for the treatment of rheumatoid arthritis
-
* Corresponding author: Eric M Ruderman e-ruderman@northwestern.edu
Arthritis Research & Therapy 2005, 7(Suppl 2):S21-S25 doi:10.1186/ar1688